Know what you really own

Unwrap both →

Fund comparison · from official SEC filings

CANC vs PRHSX: how much do they overlap?

Tema Oncology ETF and T. Rowe Price Health Sciences Fund, Inc.

Fund A

vs

Fund B

Holdings overlap

28%

of assets, by weight

Shared positions

36

of 57 / 287 holdings

CANC expense ratio

0.75%

net, per year

PRHSX expense ratio

0.83%

net, per year

Shared holdings

Company

CANC

PRHSX

L

LLYELI LILLY & CO

4.82%

10.14%

R

RVMDREVOLUTION MEDICINES INC

7.72%

1.36%

C

COGTCOGENT BIOSCIENCES INC

4.09%

0.12%

I

IMNMIMMUNOME INC

3.91%

0.33%

C

CELCCELCUITY INC

3.58%

0.56%

M

MRKMERCK & CO. INC.

3.57%

3.44%

A

AZNASTRAZENECA PLC

3.53%

3.17%

A

ABBVABBVIE INC

2.80%

2.84%

B

BBIOBRIDGEBIO PHARMA INC

2.75%

0.59%

R

REGNREGENERON PHARMACEUTICALS

0.75%

2.65%

G

GILDGILEAD SCIENCES INC

1.12%

2.60%

J

JNJJOHNSON & JOHNSON

2.54%

2.44%

C

CGONCG ONCOLOGY INC

2.43%

0.69%

I

IDYAIDEAYA BIOSCIENCES INC

2.27%

0.08%

A

AMGNAMGEN INC

2.11%

0.98%

Z

ZLABZAI LAB LTD-ADR

1.98%

0.04%

O

ONCBEONE MEDICINES LTD-ADR

1.88%

0.13%

E

ELVNENLIVEN THERAPEUTICS INC

1.31%

0.02%

R

RLAYRELAY THERAPEUTICS INC

1.28%

0.12%

S

SMMTSUMMIT THERAPEUTICS INC

1.20%

1.04%

I

IMTXIMMATICS NV

1.12%

0.04%

E

ERASERASCA INC

1.08%

0.19%

N

NUVBNUVATION BIO INC

1.07%

0.01%

N

NTRANATERA INC

0.54%

1.03%

G

GHGUARDANT HEALTH INC

0.81%

0.90%

Only in CANC

R

RHHBYROCHE HOLDINGS LTD-SPONS ADR

4.21%

N

NVSEFNOVARTIS AG-REG

4.03%

?

—Nuvalent Inc

3.37%

B

BMYBRISTOL-MYERS SQUIBB CO

3.30%

L

LEGNLEGEND BIOTECH CORP-ADR

2.99%

E

EXELEXELIXIS INC

2.77%

G

GMABGENMAB A/S -SP ADR

2.37%

Z

ZYMEZYMEWORKS INC

1.51%

H

HALOHALOZYME THERAPEUTICS INC

1.23%

R

RCUSARCUS BIOSCIENCES INC

1.20%

F

FXFXXFIRST AM TREAS OBLI-X

1.09%

A

ANABANAPTYSBIO INC

0.99%

U

URGNUROGEN PHARMA LTD

0.93%

S

SNDXSYNDAX PHARMACEUTICALS INC

0.80%

A

AVBPARRIVENT BIOPHARMA INC

0.73%

I

INBXINHIBRX BIOSCIENCES INC

0.60%

T

TRAXFIRST TRACKS BIOTHERAPEUTICS

0.53%

C

CTMXCYTOMX THERAPEUTICS INC

0.47%

H

HCMHUTCHMED CHINA-ADR

0.44%

A

ARVNARVINAS INC

0.43%

S

SLSSELLAS LIFE SCIENCES GROUP I

0.21%

Only in PRHSX

T

TMOTHERMO FISHER SCIENTIFIC INC

4.07%

I

ISRGINTUITIVE SURGICAL INC

3.65%

S

SYKSTRYKER CORP

3.46%

U

UNHUNITEDHEALTH GROUP INC

3.09%

A

ARGXARGENX SE - ADR

2.92%

V

VRTXVERTEX PHARMACEUTICALS INC

2.43%

D

DHRDANAHER CORP

2.05%

A

ALNYALNYLAM PHARMACEUTICALS INC

1.62%

?

—ASCENDIS PHARMA A/S - ADR

1.42%

U

UTHRUNITED THERAPEUTICS CORP

1.34%

B

BEIGFBEONE MEDICINES LTD-H

1.19%

R

ROIVROIVANT SCIENCES LTD

1.13%

P

PTGXPROTAGONIST THERAPEUTICS INC

1.11%

I

INSMINSMED INC

1.06%

T

THCTENET HEALTHCARE CORP

1.01%

B

BTSGBRIGHTSPRING HEALTH SERVICES

0.98%

B

BSXBOSTON SCIENTIFIC CORP

0.92%

H

HCAHCA HEALTHCARE INC

0.90%

C

CVSCVS HEALTH CORP

0.86%

K

KYMRKYMERA THERAPEUTICS INC

0.77%

C

CITHE CIGNA GROUP

0.74%

C

CAHCARDINAL HEALTH INC

0.68%

E

ELVELEVANCE HEALTH INC

0.66%

K

KRYSKRYSTAL BIOTECH INC

0.65%

S

SRRKSCHOLAR ROCK HOLDING CORP

0.62%

Hold CANC and PRHSX together? See your combined true holdings, overlap, and blended fees — free, no signup.

Unwrap your portfolio →

Other comparisons you might like

PRHSX vs FHLCFidelity MSCI Health Care Index ETF

PRHSX vs VHTVANGUARD HEALTH CARE INDEX FUND

PRHSX vs IBBQInvesco Nasdaq Biotechnology ETF

PRHSX vs BIBProShares Ultra Nasdaq Biotechnology

PRHSX vs IBBiShares Biotechnology ETF

CANC vs VHTVANGUARD HEALTH CARE INDEX FUND

Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.